[1]张燕洁,李晓玲,张莹雪,等.健脾活血利水法治疗肝硬化腹水Meta分析[J].陕西中医杂志,2023,(6):801-807.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.027]
 ZHANG Yanjie,LI Xiaoling,ZHANG Yingxue,et al.A Meta-analysis of the basic treatment of Jianpi Huoxue Lishui method in the treatment of ascites in cirrhosis[J].,2023,(6):801-807.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.027]
点击复制

健脾活血利水法治疗肝硬化腹水Meta分析
分享到:

《陕西中医》杂志[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年6期
页码:
801-807
栏目:
Meta分析
出版日期:
2023-06-05

文章信息/Info

Title:
A Meta-analysis of the basic treatment of Jianpi Huoxue Lishui method in the treatment of ascites in cirrhosis
作者:
张燕洁12李晓玲2张莹雪12李柄邑12孙凤霞2
(1.北京中医药大学,北京100029; 2.首都医科大学附属北京中医医院,北京100010)
Author(s):
ZHANG YanjieLI XiaolingZHANG YingxueLI BingyiSUN Fengxia
(Beijing University of Chinese Medicine,Beijing 100029,China)
关键词:
肝硬化腹水 健脾活血利水法 鼓胀 腹围 腹腔积液深度
Keywords:
Cirrhotic ascites Jianpi Huoxue Lishui method Tympanites Abdominal circumference Depth of ascites
分类号:
R 575.2
DOI:
DOI:10.3969/j.issn.1000-7369.2023.06.027
文献标志码:
A
摘要:
目的:系统评价依据中医鼓胀基本病理特点而确立的治法“健脾活血利水法”治疗肝硬化腹水的有效性及安全性。方法:计算机检索国内外数据库,收集健脾活血利水法治疗肝硬化腹水的随机对照研究,提取纳入文献数据并进行质量评价,利用Rev Man 5.4软件对数据进行Meta分析。结果:纳入21项研究,共1906例患者。Meta分析显示:与单纯西医常规治疗相比,联合健脾活血利水法在提升肝硬化腹水临床总有效率[OR=4.02,95%CI(3.04,5.30),P<0.00001],改善24 h尿量[MD=256.18,95%CI(164.00,348.36),P<0.00001]、腹围[MD=-4.22,95%CI(-5.15,-3.29),P<0.00001]、腹腔积液深度[MD=-0.52,95%CI(-0.67,-0.36),P<0.00001]方面均显示出优势,而在改善体重方面[MD=-1.28,95%CI(-4.26,1.70),P=0.40]差异无统计学意义。结论:在治疗肝硬化腹水方面,健脾活血利水法联合西医常规疗法,能够有效改善临床症状,增加24 h尿量,减少腹围和腹腔积液深度。
Abstract:
Objective:To systematically evaluate the efficacy and safety of the treatment based on basic pathological characteristics of traditional Chinese medicine “Jianpi Huoxue Lishui” method combined with conventional western medicine in the treatment of ascites due to cirrhosis.Methods:Databases domestic and abroad were searched by computer to collect randomised controlled studies on the treatment of liver cirrhosis with ascites by strengthening the spleen,promoting blood circulation and diverting water.The included literature was extracted and the quality of the data was evaluated.Rev Man 5.4 software was used to carry out Meta-analysis of the data.Results:21 studies were included,with a total of 1906 patients.Meta-analysis showed that compared with conventional western medicine treatment alone,combined with the method of strengthening the spleen and promoting blood circulation and diuresis in improving the total clinical effective rate of liver cirrhosis ascites [OR=4.02,95%CI(3.04,5.30),P<0.00001],improved 24 h urine output [MD=256.18,95%CI(164.00,348.36),P<0.00001],abdominal circumference [MD=-4.22,95%CI(-5.15,-3.29), P<0.00001],depth of ascites [MD=-0.52,95%CI(-0.67,-0.36),P<0.00001] all showed advantages,while in terms of weight improvement [MD=-1.28,95%CI(-4.26,1.70),P=0.40] no significant difference.Conclusion:The method of Jianpi Huoxue Lishui method combined with conventional western medicine therapy in the treatment of liver cirrhosis ascites can effectively improve the clinical symptoms,increase the 24-hour urine volume,and reduce the abdominal circumference and the depth of ascites.

参考文献/References:

[1] 范开春,程留芳.肝硬化腹水发生机制[J].中华肝脏病杂志,2003,11(3):53.
[2] Rudler M,Mallet M,Sultanik P,et al.Optimal management of ascites[J].Liver Int,2020,40(1):128-135.
[3] 徐小元,丁惠国,李文刚,等.肝硬化腹水及相关并发症的诊疗指南[J].临床肝胆病杂志,2017,33(10):1847-1863.
[4] 张会涛,尚 丽,李秋雅,等.护肝利水汤联合特利加压素治疗肝硬化腹水临床疗效及对患者血清学指标与门静脉压力的影响[J].陕西中医,2020,41(5):593-596.
[5] 田莉婷,刘雪萍,李丹妮,等.加味苓桂术甘汤对脾肾阳虚型肝硬化失代偿期患者生存率的影响[J].陕西中医,2019,40(10):1373-1376.
[6] 张声生,王宪波,江宇泳.肝硬化腹水中医诊疗专家共识意见(2017)[J].临床肝胆病杂志,2017,33(9):1621-1626.
[7] 张莉莉,陈 豪,李成行,等.健脾活血利水方对脾虚水停证乙型肝炎肝硬化腹水疗效及T淋巴细胞亚群影响[J].中西医结合肝病杂志,2021,31(8):695-698.
[8] 李淑红,刘华一,唐艳萍.健脾活血利水汤治疗乙肝肝硬化腹水的疗效及安全性[J].现代中西医结合杂志,2016,25(9):944-947.
[9] 张丽珍,韩国华.健脾活血利水冲剂治疗肝硬化腹水60例临床观察[J].潍坊医学院学报,2007,29(4):354-355.
[10] 田密昌.健脾活血利水方联合西药治疗脾虚血瘀肝硬化腹水随机平行对照研究[J].实用中医内科杂志,2018,32(2):41-44.
[11] 徐保平.健脾化瘀利水汤联合利尿剂治疗肝硬化腹水32例[J].中医研究,2009,22(3):42-44.
[12] 李留霞.健脾化瘀利水法治疗肝硬化腹水临床观察[J].中国中医急症,2007,16(5):538-539.
[13] 田兰清.健脾化瘀利水方治疗乙肝后肝硬化腹水60例临床观察[J].世界最新医学信息文摘,2019,19(68):207-208.
[14] 谢玉兰,勾春燕,李 丽,等.健脾活血利水方治疗肝硬化腹水的临床观察[J].中国中医急症,2015,24(12):2233-2235.
[15] 陈 鹏,曹武奎.益气健脾活血利水汤联合西医治疗肝硬化合并腹水疗效观察[J].现代中西医结合杂志,2017,26(18):1999-2001.
[16] 吕向阳.中西医结合治疗肝硬化46例[J].中国中医药现代远程教育,2009,7(12):246-247.
[17] 马晓杰,陈新谱.健脾活血利水汤治疗乙型肝炎肝硬化腹水的疗效观察[J].中国医药指南,2020,18(10):173-174.
[18] 林树煌,邹小玲,张美玲.益气健脾活血利水汤联合西药治疗乙肝后肝硬化腹水随机平行对照研究[J].实用中医内科杂志,2015,29(5):125-126.
[19] 廖 慧.中西医结合治疗肝硬化合并腹水44例疗效观察[J].中医药导报,2008,14(11):45-46.
[20] 赵晓艳.健脾活血利水法治疗乙肝后肝硬化腹水的疗效观察[D].广州:广州中医药大学,2008.
[21] 张学斌,张北平.以健脾逐瘀利水法为主治疗肝硬化腹水的临床观察[J].广州中医药大学学报,2002,19(4):272-274.
[22] 张培钦,邱仁斌,温伟平,等.健脾化瘀利水法治疗肝硬化腹水的临床研究[J].中国中医药科技,2003,10(2):74-75.
[23] 杨志刚.益气健脾活血利水汤联合西医治疗肝硬化合并腹水的临床疗效观察[J].中国保健营养,2017,27(31):118.
[24] 杨小红.健脾活血利水法治疗肝硬化腹水的理论与临床研究[D].南京:南京中医药大学,2005.
[25] 王立霏.健脾化瘀利水法联合腹水超滤浓缩回输腹腔术治疗肝硬化顽固性腹水的临床研究[D].武汉:湖北中医药大学,2013.
[26] 钱静燕.健脾化瘀利水方治疗乙肝后肝硬化腹水110例临床观察[J].世界中医药,2014,9(12):1609-1611,1615.
[27] 马建红.治腹水汤药结合西药治疗肝硬化腹水42例临床观察[J].健康必读:中旬刊,2011,16(1):40-41.
[28] 王 磊.肝硬化腹水的中西医结合诊治[J].临床肝胆病杂志,2022,38(9):1956-1961.
[29] Biggins SW,Angeli P,Garcia TG,et al.Diagnosis,evaluation,and management of ascites,spontaneous bacterial peritonitis and hepatorenal syndrome:2021 practice guidance by the american association for the study of liver diseases[J].Hepatology,2021,74(2):1014-1048.
[30] 李 追,曾珂芮,李生伟.中西医结合治疗肝硬化顽固性腹水的Meta分析[J].现代医药卫生,2019,35(16):2462-2465,2593.
[31] 高尚社.国医大师朱良春教授辨治肝硬化腹水验案赏析[J].中国中医药现代远程教育,2013,11(23):7-9.
[32] 张 楠,卢秉久.卢秉久教授治疗肝硬化腹水经验[J].湖南中医杂志,2013,29(3):26-27.
[33] 王亚红,吉兴旺.刘铁军教授对肝硬化腹水病因病机的认识[J].中国医药指南,2016,14(14):200-202.
[34] 赵伯智.关幼波肝病杂病论[M].2版.北京:中国医药科技出版社,2013:62-63.
[35] 刘嘉辉,邝卫红.名老中医治疗肝硬化腹水用药规律分析[J].江苏中医药,2014,46(1):69-70.
[36] 黄春丽,冯光维,许义红,等.泽泻化学成分及药理作用研究进展[J].广东化工,2021,48(10):106-108.
[37] 马艳春,范楚晨,冯天甜,等.茯苓的化学成分和药理作用研究进展[J].中医药学报,2021,49(12):108-111.
[38] 周小文,王雅欣,闫振乾,等.茯苓-泽泻药对对高脂血症痰浊证ApoE-/-小鼠肝、肾组织中水通道蛋白的作用研究[J].中国中医基础医学杂志,2022,28(6):886-891.
[39] 刘 明,王慧森,梁瑞峰,等.茯苓-泽泻药对配伍研究及其标准煎液对肾病模型大鼠的影响[J].中国药师,2022,25(8):1317-1323.
[40] 冯科冉,李伟霞,王晓艳,等.丹参化学成分、药理作用及其质量标志物(Q-Marker)的预测分析[J].中草药,2022,53(2):609-618.

相似文献/References:

[1]杨广栋,高志远,李卫民,等.益气活血利水贴敷脐治疗肝硬化腹水疗效及对患者生存质量研究*[J].陕西中医杂志,2019,(11):1503.
 YANG Guangdong,GAO Zhiyuan,LI Weimin,et al.The clinical efficacy and quality of life evaluation of Yiqi Huoxue Lishui stick in treating ascites due to cirrhosis[J].,2019,(6):1503.
[2]张会涛,尚 丽,李秋雅,等.护肝利水汤联合特利加压素治疗肝硬化腹水临床疗效及对患者血清学指标与门静脉压力的影响*[J].陕西中医杂志,2020,(5):593.[doi:DOI:10.3969/j.issn.10007369.2020.05.011]
 ZHANG Huitao,SHANG Li,LI Qiuya,et al.Effects of Hugan Lishui decoction combined with terlipressin on clinical efficacy,serum index and portal venous pressure in patients with liver cirrhosis and ascites[J].,2020,(6):593.[doi:DOI:10.3969/j.issn.10007369.2020.05.011]
[3]陈毅然,张文富.基于分段论治理论治疗肝硬化腹水研究进展[J].陕西中医杂志,2023,(10):1487.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.035]
 CHEN Yiran,ZHANG Wenfu.Research progress on the treatment of cirrhotic ascites based on the theory of segmented treatment[J].,2023,(6):1487.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.035]

备注/Memo

备注/Memo:
基金项目:国家科技重大专项“十三五”课题(2018ZX10725-505); 首都卫生发展科研专项课题(2018-2-2173)
更新日期/Last Update: 2023-06-09